Year 2017 Vol. 25 No 4




FSBEE HE Dagestan State Medical University,
The Russian Federation

The paper aims to present the review of literature on acute intestinal obstruction in case of the reperfusion syndrome. Ischaemia reperfusion syndrome is a complex pathological process characterized by initial restriction of blood supply to the organ followed by subsequent restoration of blood flow, has a significant impact on cell membrane integrity and activation of the lipid peroxidation process. Resulted from the cell membrane permeability, excessive cytokine and proteolytic enzymatic activity leads to the dysfunction of the kallikrein-kinin and hemostasis system and thus plays an important role in the mechanism of the perfusion development. Ischemia/reperfusion syndrome is characterized by mostly nonspecific abnormalities in coagulation profile, general and biochemical analysis. However, dynamics of the syndrome can be based on changing the levels of more specific markers that are not routinely assessed yet, probably due to expensive reagents. Presently, there is no uniform tactics of treatment and prevention of reperfusion syndrome despite the attempts to treat patients by hypothermia, antioxidants, protease inhibitors, and anticoagulants. Therefore, basing on the literature data it should be noteworthy that early diagnostics and treatment of reperfusion syndrome still remain difficult not completely solved issue.

Keywords: acute intestinal obstruction, reperfusion syndrome, lipid peroxidation, hemostasis system, oxidative distress, treatment, prevention, endothelial dysfunction
p. 404-411 of the original issue
  1. Burchett G. The effect of coronary occlusion on myocardial contractility in dogs. J Am Osteopath Assoc. 1968 May;67(9):1020-24.
  2. Schoenberg MH, Muhl E, Sellin D, Younes M, Schildberg FW, Haglund U. Posthypotensive generation of superoxide free radicals--possible role in the pathogenesis of the intestinal mucosal damage. Acta Chir Scand. 1984;150(4):301-9.
  3. Parks DA, Granger DN. Contributions of ischemia and reperfusion to mucosal lesion formation. Am J Physiol. 1986 Jun;250(6 Pt 1):G749-53.
  4. Basarab DA, Bagdasarov VV, Bagdasarova EA, Zelenskii AA, Ataian AA. Patofiziologicheskie aspekty problemy ostroi intestinal'noi ishemii [Pathophysiological aspects of acute intestinal ischemia]. Infektsii v Khirurgii. 2012;10(2):6-13.
  5. Cotran RS, Kumar V, Robbins SL, Schoen FJ. Inflammation and repair. In: Robbins Pathologic Basis of Disease. 5th ed. Philadelphia: WB Saunders Company; 1994. p. 51-93.
  6. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol. 1988 Dec;255(6 Pt 2):H1269-75.
  7. Cerqueira NF, Hussni CA, Yoshida WB. Pathophysiology of mesenteric ischemia/reperfusion: a review. Acta Cir Bras. 2005 Jul-Aug;20(4):336-43.
  8. Granger DN. Ischemia-reperfusion: mechanisms of microvascular dysfunction and the influence of risk factors for cardiovascular disease. Microcirculation. 1999 Sep;6(3):167-78.
  9. Braunersreuther V, Jaquet V. Reactive oxygen species in myocardial reperfusion injury: from physiopathology to therapeutic approaches. Curr Pharm Biotechnol. 2012 Jan;13(1):97-114.
  10. Grootjans J, Lenaerts K, Derikx JP, Matthijsen RA, de Bruïne AP, van Bijnen AA, et al. Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model. Am J Pathol. 2010 May;176(5):2283-91. doi: 10.2353/ajpath.2010.091069.
  11. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000 Feb;190(3):255-66.
  12. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol. 1988 Dec;255(6 Pt 2):H1269-75.
  13. Farrar CA, Asgari E, Schwaeble WJ, Sacks SH. Which pathways trigger the role of complement in ischaemia/reperfusion injury? Front Immunol. 2012 Nov;3. Art 341. doi: 10.3389/fimmu.2012.00341.
  14. Rodrigues SF, Granger DN. Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure. Cardiovasc Res. 2010 Jul 15;87(2):291-99. doi: 10.1093/cvr/cvq090.
  15. Chtourou Y, Aouey B, Aroui S, Kebieche M, Fetoui H. Anti-apoptotic and anti-inflammatory effects of naringin on cisplatin-induced renal injury in the rat. Chem Biol Interact. 2016 Jan 5;243:1-9. doi: 10.1016/j.cbi.2015.11.019. Epub 2015 Nov 21.
  16. Alverdy JC, Chang EB. The re-emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away. J Leukoc Biol. 2008 Mar;83(3):461-6.
  17. Chen LW, Chang WJ, Chen PH, Liu WC, Hsu CM. TLR ligand decreases mesenteric ischemia and reperfusion injury-induced gut damage through TNF-alpha signaling. Shock. 2008 Nov;30(5):563-70. doi: 10.1097/SHK.0b013e31816a3458.
  18. Dzieciatkowska M, Wohlauer MV, Moore EE, Damle S, Peltz E, Campsen J, et al. Proteomic analysis of human mesenteric lymph. Shock. 2011 Apr;35(4):331-38. doi: 10.1097/SHK.0b013e318206f654.
  19. Seal JB, Gewertz BL. Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg. 2005 Jul;19(4):572-84.
  20. Cooper D, Chitman KD, Williams MC, Granger DN. Time-dependent platelet-vessel wall interactions induced by intestinal ischemia-reperfusion. Am J Physiol Gastrointest Liver Physiol. 2003 Jun;284(6):G1027-33.
  21. Choudhury NA, Malyszko J, Ahmed MH, Pietraszek MH, Nakamura S, Nakai K, et al. Plasma serotonin and platelet aggregation during ischemia-reperfusion in dogs: effect of dipyridamole and coenzyme Q10. Haemostasis. 1996 Jan-Feb;26(1):38-44.
  22. Nakamura N, Hamada N, Murata R, Ishizaki N, Kobayashi A, Moriyama Y. Liver injury and serotonin production after small intestinal ischemia and reperfusion. Transplant Proc. 2000 Sep;32(6):1301.
  23. 23. Iushkevich DV, Ladut'ko IM, Khryshchanovich VIa, Novichenko AS. Vozmozhnosti interventsionnoi radiologii i sistemnogo trombolizisa v diagnostike i lechenii ostrogo narusheniia mezenterial'nogo krovoobrashcheniia [Possibilities of interventional radiology and systemic thrombolysis in the diagnosis and treatment of acute mesenteric circulation disorders]. Voen Meditsina. 2012;(2):136-38.
  24. Arakawa K, Takeyoshi I, Muraoka M, Matsumoto K, Morishita Y. Measuring platelet aggregation to estimate small intestinal ischemia-reperfusion injury. J Surg Res. 2004;122(2):195-200. doi: 10.1016/j.jss.2004.07.011.
  25. Park PO, Haglund U, Bulkley GB, Fält K. The sequence of development of intestinal tissue injury after strangulation ischemia and reperfusion. Surgery. 1990 May;107(5):574-80.
  26. Osman AH, Bashandy MM, Said NM, Elghoul WS. Pathological and clinicopathological studies on reperfusion of ischemic intestine. Egypt J Comp Path & Clinic Path. 2008 Apr;21(2):1-26.
  27. Cho SS, Rudloff I, Berger PJ, Irwin MG, Nold MF, Cheng W, et al. Remifentanil ameliorates intestinal ischemia-reperfusion injury. BMC Gastroenterol. 2013 Apr 22;13:69. doi: 10.1186/1471-230X-13-69.
  28. Savas C1, Ozogul C, Karaöz E, Delibas N, Ozgüner F. Splenectomy reduces remote organ damage after intestinal ischaemia-reperfusion injury. Acta Chir Belg. 2003 Jun;103(3):315-20.
  29. Stallion A, Kou TD, Latifi SQ, Miller KA, Dahms BB, Dudgeon DL, et al. Ischemia/reperfusion: a clinically relevant model of intestinal injury yielding systemic inflammation. J Pediatr Surg. 2005 Mar;40(3):470-77.
  30. Petrat F, Swoboda S, de Groot H, Schmitz KJ. Quantification of ischemia-reperfusion injury to the small intestine using a macroscopic score. J Invest Surg. 2010 Aug;23(4):208-17. doi: 10.3109/08941931003623622.
  31. Ladipo JK, Seidel SA, Bradshaw LA, Halter S, Wikswo JP Jr, Richards WO. Histopathologic changes during mesenteric ischaemia and reperfusion. West Afr J Med. 2003 Jan-Mar;22(1):59-62.
  32. Matthijsen RA, Derikx JPM, Kuipers D, van Dam RM, Dejong CHC, Buurman WA. Enterocyte shedding and epithelial lining repair following ischemia of the human small intestine attenuate inflammation. PLoS One. 2009; 4(9): e7045. doi: 10.1371/journal.pone.0007045.
  33. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch Surg. 1970 Oct;101(4):478-83.
  34. Quaedackers JS1, Beuk RJ, Bennet L, Charlton A, oude Egbrink MG, Gunn AJ, Heineman E. An evaluation of methods for grading histologic injury following ischemia/reperfusion of the small bowel. Transplant Proc. 2000 Sep;32(6):1307-10.
  35. Parks DA, Bulkley GB, Granger DN, Hamilton SR, McCord JM. Ischemic injury in the cat small intestine: role of superoxide radicals. Gastroenterology. 1982 Jan;82(1):9-15.
  36. Sonnino RE1, Riddle JM, Pritchard TJ. Grading system for histologic changes in rat small bowel transplants. Transplant Proc. 1992 Jun;24(3):1201-2.
  37. Idrovo JP, Yang WL, Jacob A, Aziz M, Nicastro J, Coppa GF, et al. AICAR attenuates organ injury and inflammatory response after intestinal ischemia and reperfusion. Mol Med. 2015 Mar 19;20:676-83. doi: 10.2119/molmed.2014.00134.
  38. Pierro A, Eaton S. Intestinal ischemia reperfusion injury and multisystem organ failure. Semin Pediatr Surg. 2004 Feb;13(1):11-7.
  39. de Arruda MJ, Poggetti RS, Fontes B, Younes RN, Souza AL Jr, Birolini D. Intestinal ischemia/reperfusion induces bronchial hyperreactivity and increases serum TNF-alpha in rats. Clinics (Sao Paulo). 2006 Feb;61(1):21-8.
  40. Stringa P, Lausada N, Romanin D, Portiansky E, Zanuzzi C, Machuca M, et al. Pretreatment Combination Reduces Remote Organ Damage Secondary to Intestinal Reperfusion Injury in Mice: Follow-up Study. Transplant Proc. 2016 Jan-Feb;48(1):210-16. doi: 10.1016/j.transproceed.2015.12.002.
Address for correspondence:
367000, Russian Federation,
Republic of Dagestan, Makhachkala,
Pirogov st., 3, FSBEE HE "Dagestan State
Medical University", Department of Surgery
Tel.: 79282308646,
Muhuma M. Magomedov
Information about the authors:
Magomedov M.M. MD, Professor of department of the advanced training and retraining of the medical specialists.
Batsikov K.A. Post-graduate student of department of the advanced training and retraining of the medical specialists, FSBEE HE Dagestan State Medical University.
Contacts | ©Vitebsk State Medical University, 2007-2023